Richard Mulligan - Net Worth and Insider Trading
Richard Mulligan Net Worth
The estimated net worth of Richard Mulligan is at least $8 Million dollars as of 2024-11-10. Richard Mulligan is the Director of Sana Biotechnology Inc and owns about 2,698,121 shares of Sana Biotechnology Inc (SANA) stock worth over $8 Million. Richard Mulligan is also the Director of Biogen Inc and owns about 2,020 shares of Biogen Inc (BIIB) stock worth over $349,500. Details can be seen in Richard Mulligan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard Mulligan has not made any transactions after 2024-09-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard Mulligan
Richard Mulligan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard Mulligan owns 4 companies in total, including Biogen Inc (BIIB) , Enzon Pharmaceuticals Inc (ENZN) , and Bausch Health Companies Inc (BHC) among others .
Click here to see the complete history of Richard Mulligan’s form 4 insider trades.
Insider Ownership Summary of Richard Mulligan
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
BIIB | Biogen Inc | 2013-05-28 | director |
ENZN | Enzon Pharmaceuticals Inc | 2010-07-01 | director |
BHC | Bausch Health Companies Inc | 2022-05-10 | director |
2024-09-25 | director & Head of SanaX |
Richard Mulligan Latest Holdings Summary
Richard Mulligan currently owns a total of 2 stocks. Among these stocks, Richard Mulligan owns 2,698,121 shares of Sana Biotechnology Inc (SANA) as of September 25, 2024, with a value of $8 Million and a weighting of 95.87%. Richard Mulligan also owns 2,020 shares of Biogen Inc (BIIB) as of May 28, 2013, with a value of $349,500 and a weighting of 4.13%.
Latest Holdings of Richard Mulligan
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SANA | Sana Biotechnology Inc | 2024-09-25 | 2,698,121 | 3.01 | 8,107,854 |
BIIB | Biogen Inc | 2013-05-28 | 2,020 | 173.02 | 349,500 |
Holding Weightings of Richard Mulligan
Richard Mulligan Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard Mulligan has made a total of 1 transactions in Sana Biotechnology Inc (SANA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Sana Biotechnology Inc is the sale of 300,000 shares on September 25, 2024, which brought Richard Mulligan around $1 Million.
According to the SEC Form 4 filings, Richard Mulligan has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 37,975 shares on May 28, 2013, which brought Richard Mulligan around $9 Million.
Insider Trading History of Richard Mulligan
- 1
Richard Mulligan Trading Performance
Richard Mulligan Ownership Network
Ownership Network List of Richard Mulligan
Ownership Network Relation of Richard Mulligan
Richard Mulligan Owned Company Details
What does Biogen Inc do?
Who are the key executives at Biogen Inc?
Richard Mulligan is the director of Biogen Inc. Other key executives at Biogen Inc include Head of Development Priya Singhal , Head of Research Jane Grogan , and EVP & Human Resources Ginger Gregory .
Biogen Inc (BIIB) Insider Trades Summary
Over the past 18 months, Richard Mulligan made no insider transaction in Biogen Inc (BIIB). Other recent insider transactions involving Biogen Inc (BIIB) include a net sale of 2,569 shares made by Priya Singhal , and a net purchase of 455 shares made by Eric K Rowinsky .
In summary, during the past 3 months, insiders sold 431 shares of Biogen Inc (BIIB) in total and bought 0 shares, with a net sale of 431 shares. During the past 18 months, 2,569 shares of Biogen Inc (BIIB) were sold and 455 shares were bought by its insiders, resulting in a net sale of 2,114 shares.
Biogen Inc (BIIB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biogen Inc Insider Transactions
Richard Mulligan Mailing Address
Above is the net worth, insider trading, and ownership report for Richard Mulligan. You might contact Richard Mulligan via mailing address: C/o Icahn Capital Lp, 767 Fifth Avenue, Suite 4700, New York Ny 10153.